Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study

Abstract

Gamma-aminobutyric acid-A (GABA-A) receptors play a crucial role in regulating neuronal excitability and cognitive functions. Single-photon emission computerized tomography (SPECT) analysis of GABA-A receptors binding by ¹²³I-labelled Iomazenil (¹²³I-IMZ) has been applied in some neuropsychiatric disorders to investigate conditions where GABA-A receptor density can be detected in several pathophysiological conditions. In this study we investigate cerebral GABA-A receptor density in a small series of patients with systemic lupus erythematosus (SLE) and cognitive impairment characterized by recurrent, episodic memory loss. Nine female patients with SLE and cognitive alterations underwent to a clinical neuropsychiatric evaluation including digital video-EEG, brain MRI, ^99mTc-ECD brain SPECT and ¹²³I-IMZ brain SPECT. All patients tested showed diffuse or focal GABA-A receptor density reduction. This is, to our knowledge, the first report on GABA-A receptor density abnormalities associated with cognitive defects in SLE patients. We hypothesize that in our series a decrease in GABA-A receptor density might be related to the neurological manifestations. Further studies are needed to clarify this aspect and the possible mechanisms. GABA-A receptor density impairment might be due to the SLE-related cerebral vasculopathy, or to neuronal-reacting auto-antibodies or drugs which could interfere with GABA-A receptors expression/binding. This study may support the concept that cognitive impairment in systemic lupus erythematosus could be the outcome of fine-tuned neurotransmission alterations.

Keywords

systemic lupus erythematosus central nervous system cognitive defects 123I-Iomazenil brain SPECT 99mTc-ECD brain SPECT GABA-A receptor

Get full access to this article

View all access options for this article.

References

Hanly JG , Fisk JD , Sherwood G. , Jones E. , Jones JV , Eastwood B. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 1992; 19: 562-567.

Hay EM , Black D. , Huddy A. , et al. Psychiatric disorders and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 411-416.

Newman SP Cognitive changes in systemic lupus erythematosus. Baillieres Clin Rheum 1993; 7: 357-376.

ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.

Abi-Dargham A. , Gandellman M. , Zoghbi SS Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with Iodine-123-Iomazenil. J Nucl Med 1995; 36: 167-175.

Onishi Y. , Yonekura Y. , Nishizawa S. , Tanaka F. Noninvasive qualification of Iodine-123-Iomazenil SPECT. J Nucl Med 1996; 37: 374-378.

Abi-Dargham A. , Laruelle M. , Seibyl J. , Rattner Z. , Baldwin RM , Zoghbi SS SPECT measurement of benzodiazepine receptors in human brain Iodine-123-Iomazenil: kinetic and equilibrium paradigms. J Nucl Med 1994; 35: 228-238.

Borbely K. Functional imaging (PET and SPECT) in epilepsy. Orv Hethyl 2001; 142: 2405-2414.

Marrosu F. , Serra A. , Maleci A. , Puligheddu M. , Biggio G. , Piga M. Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy. Epilepsy Res 2003; 55: 59-70.

10.

Morimoto K. , Watanabe T. , Ninomiya T. , et al. Quantitative evaluation of central-type benzodiazepine receptors with [(125)I] Iomazenil in experimental epileptogenesis: II. The rat cortical dysplasia model. Epilepsy Res 2004; 61: 113-118.

11.

Abi-Dargham A. , Krystal JH , Anjilvel S. , et al. Alterations of benzodiazepine receptors in type II alchoolic sibjects measured with SPECT and [123I] iomazenil. Am J Psychiatry 1998; 155: 1550-1555.

12.

Lingford-Hughes AR , Acton PD , Gacinovic S. , et al. Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy. Br J Psychiatry 1998; 173: 116-122.

13.

Bremner JD , Inis RB , White T. , et al. SPECT [I-123] iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry 2000; 15: 96-106.

14.

Schroder J. , Bubeck B. , Demish S. , Sauer H. Benzodiazepine receptor distribution and diazepam binding in schizophrenia: an exploratory syudy. Psychiatry Res 1997; 68: 125-131.

15.

Ohyama M. , Senda M. , Ishiwata K. , et al. Preserved benzodiazepine receptors in Alzheimer’s disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF. Ann Nucl Med 1999; 13: 309-315.

16.

Tan EM , Cohen AS , Fries JF , et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.

17.

Mathieu A. , Sanna G. , Mameli A. , et al. Sustained normalization of cerebral blood-flow after iloprost therapy in a patient with neuropsychiatric systemic lupus erythematosus. Lupus 2002; 11: 52-56.

18.

DeLorey TM , Lin RC , McBrady B. , et al. Influence of benzodiazepine binding site ligands on fear-conditioned contextual memory. Eur J Pharmacol 2001; 426: 45-54.

19.

Diez-Ariza M. , Redondo C. , Garcia-Alloza M. , Lasheras B. , Del Rio J. , Ramirez MJ Flumazenil and taurine increase the effectiveness of ondastreon on scopolamine-induced impairment of spatial learning in rats . Psychopharmacology 2003; 169: 35-41.

20.

Maubach K. GABA(A) receptor subtype selective cognition enhancers. Curr Drug Targets CNS Neurol Disord 2003; 2: 233-239.

21.

Johnston GA , Chebib M. , Hanrahan JR , Mewett KN GABA(C) receptors as drug targets. Curr Drug Targets CNS Neurol Disord 2003; 2: 260-269.

22.

Rissman RA , Bennett DA , Armstrong DM Subregional analysis of GABA(A) receptor subunit mRNAs in the hippocampus of older persons with and without cognitive impairment. J Chem Neuroanat 2004; 28: 17-25.

23.

Goodwin GM Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. J Psychopharmacol 1997 ; 11: 115-122.

24.

Kugaya A. , Sanacora G. , Verhoeff NP , et al. Cerebral benzodiazepine receptors in depressed patients measured with [123I] iomazenil SPECT. Biol Psychiatry 2003; 15: 792-799.

25.

Muller V. , Saur D. , Klutmann S. , Weiller C. , Rother J. , Clausen M. Experience with 123I-iomazenil SPECT in acute cerebral infarction. Nucl Med Commun 2002; 23: 1191-1196.

26.

Hatazawa J. , Shimosegawa E. Imaging neurochemistry of cerebrovascular disease with PET and SPECT. Q J Nucl Med 1998 ; 42: 193-98.

27.

Nakagawara J. , Sperling B. , Lassen NA Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil. Stroke 1997; 28: 124-132.

28.

Shuke N. , Hashizume K. , Kiruyama K. , et al. Correct localization of epilectogenic focus with I-123 iomazenil cerebral benzodiazepine receptor imaging: a case report of temporal lobe epilepsy with discordant ictal cerebral blood flow SPECT. Ann Nucl Med 2004; 18: 541-545.

29.

Rasmussen LS , Sperling B. , Abildstrom HH , Moller JT Neuron loss after coronary artery bypass detected by SPECT estimation of benzodiazepine receptors. Ann Thorac Surg 2002; 74: 1576-1580.

30.

Sanna G. , Piga M. , Terryberry JW , et al. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus 2000 ; 9: 573-583.

31.

Liou HH , Wang CR , Chou HC , et al. Anticardiolipin antisera from lupus patients with seizures reduce a GABA receptor-mediated chloride current in snail neurons. Life Sci 1994; 54: 1119-1125.

32.

De Souza EB , Goeders NE , Kuhar MJ Benzodiazepine receptors in rat brain are altered by adrenalectomy. Brain Res 1986; 381: 176-181.

33.

Ariyoshi M. , Akasu T. Glucocorticoids modulate the sensitivity of GABA A receptor on primary afferent neurons of bullfrogs. Brain Res 1986; 367: 332-336.

34.

Liu L. , Katz Y. , Weizman R. , Rosenberg B. , Pasternak GW , Gavish M. Interactions of chloroquine with benzodiazepine, gamma-aminobutyric acid and opiate receptors. Biochem Pharmacol 1991; 41: 1534-1536.

35.

Amabeoku GJ , Chikuni O. Effects of some GABAergic agents on quinine-induced seizures in mice. Experientia 1992; 48: 659-662.